{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the PTEN induced putative kinase 1 (PINK1) gene cause an autosomal recessive form of Parkinson disease (PD). The pathogenic mechanisms by which PINK1 mutations lead to neurodegeneration are unknown.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to PINK1 mutations leading to neurodegeneration in Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses in vitro kinase assays and in vivo phosphorylation assays to assess the kinase activity of PINK1 and its mutants.",
          "judgment": "Yes",
          "reasoning": "Kinase assays are a standard method for evaluating the function of kinase proteins, which is directly related to the disease mechanism involving PINK1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of both in vitro and in vivo assays with appropriate controls and conditions to assess the kinase activity of PINK1 and its mutants."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "The relative level of in vitro TRAP1 phosphorylation was measured by quantifying the amount of 32P incorporated into TRAP1 and was normalized against the level of total TRAP1. For in vivo phosphorylation, the intensity of the phosphoserine-immunoreactive band was normalized against the level of total TRAP1.",
            "judgment": "Yes",
            "reasoning": "The paper provides statistical analysis by normalizing the phosphorylation levels against total protein levels, allowing for a quantitative measure of the functional impact of the G309D mutation."
          },
          "sub_step_4b": {
            "step_name": "Sub-step 4b: No OddsPath Calculation",
            "judgment": "No",
            "reasoning": "While the paper provides statistical analysis, it does not directly calculate OddsPath, thus requiring inference from the data provided."
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "judgment": "Yes",
            "reasoning": "Based on the data provided, the G309D mutation significantly reduces the kinase activity of PINK1, which can be inferred to correlate with a high OddsPath value indicating pathogenicity.",
            "next_step_or_outcome": "PS3_very_strong"
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The G309D mutation in PINK1 significantly impairs the kinase activity of PINK1, reducing its ability to phosphorylate TRAP1 both in vitro and in vivo. This functional evidence, combined with the statistical analysis provided, supports a very strong pathogenicity rating for this variant."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the PTEN induced putative kinase 1 (PINK1) gene cause an autosomal recessive form of Parkinson disease (PD). The pathogenic mechanisms by which PINK1 mutations lead to neurodegeneration are unknown.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to PINK1 mutations leading to neurodegeneration in Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses in vitro kinase assays and in vivo phosphorylation assays to assess the kinase activity of PINK1 and its mutants.",
          "judgment": "Yes",
          "reasoning": "Kinase assays are a standard method for evaluating the function of kinase proteins, which is directly related to the disease mechanism involving PINK1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of both in vitro and in vivo assays with appropriate controls and conditions to assess the kinase activity of PINK1 and its mutants."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "The relative level of in vitro TRAP1 phosphorylation was measured by quantifying the amount of 32P incorporated into TRAP1 and was normalized against the level of total TRAP1. For in vivo phosphorylation, the intensity of the phosphoserine-immunoreactive band was normalized against the level of total TRAP1.",
            "judgment": "Yes",
            "reasoning": "The paper provides statistical analysis by normalizing the phosphorylation levels against total protein levels, allowing for a quantitative measure of the functional impact of the L347P mutation."
          },
          "sub_step_4b": {
            "step_name": "Sub-step 4b: No OddsPath Calculation",
            "judgment": "No",
            "reasoning": "While the paper provides statistical analysis, it does not directly calculate OddsPath, thus requiring inference from the data provided."
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "judgment": "Yes",
            "reasoning": "Based on the data provided, the L347P mutation significantly reduces the kinase activity of PINK1, which can be inferred to correlate with a high OddsPath value indicating pathogenicity.",
            "next_step_or_outcome": "PS3_very_strong"
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The L347P mutation in PINK1 significantly impairs the kinase activity of PINK1, reducing its ability to phosphorylate TRAP1 both in vitro and in vivo. This functional evidence, combined with the statistical analysis provided, supports a very strong pathogenicity rating for this variant."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "W",
          "alt": "X",
          "position": "437"
        },
        "variant_string_id": "PINK1 W437X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the PTEN induced putative kinase 1 (PINK1) gene cause an autosomal recessive form of Parkinson disease (PD). The pathogenic mechanisms by which PINK1 mutations lead to neurodegeneration are unknown.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to PINK1 mutations leading to neurodegeneration in Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses in vitro kinase assays and in vivo phosphorylation assays to assess the kinase activity of PINK1 and its mutants.",
          "judgment": "Yes",
          "reasoning": "Kinase assays are a standard method for evaluating the function of kinase proteins, which is directly related to the disease mechanism involving PINK1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of both in vitro and in vivo assays with appropriate controls and conditions to assess the kinase activity of PINK1 and its mutants."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "The relative level of in vitro TRAP1 phosphorylation was measured by quantifying the amount of 32P incorporated into TRAP1 and was normalized against the level of total TRAP1. For in vivo phosphorylation, the intensity of the phosphoserine-immunoreactive band was normalized against the level of total TRAP1.",
            "judgment": "Yes",
            "reasoning": "The paper provides statistical analysis by normalizing the phosphorylation levels against total protein levels, allowing for a quantitative measure of the functional impact of the W437X mutation."
          },
          "sub_step_4b": {
            "step_name": "Sub-step 4b: No OddsPath Calculation",
            "judgment": "No",
            "reasoning": "While the paper provides statistical analysis, it does not directly calculate OddsPath, thus requiring inference from the data provided."
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "judgment": "Yes",
            "reasoning": "Based on the data provided, the W437X mutation has a smaller but significant inhibitory effect on in vivo TRAP1 phosphorylation and cell survival, which can be inferred to correlate with a moderate OddsPath value indicating pathogenicity.",
            "next_step_or_outcome": "PS3_moderate"
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The W437X mutation in PINK1 has a significant inhibitory effect on the kinase activity of PINK1, reducing its ability to phosphorylate TRAP1 in vivo. This functional evidence, combined with the statistical analysis provided, supports a moderate pathogenicity rating for this variant."
    }
  ]
}